EMBL: 'Well Prepared' to Address 'Big' Science Despite Loss Due to Dip in EC Funding | GenomeWeb

By Alex Philippidis

NEW YORK (GenomeWeb News) — The European Molecular Biology Laboratory is "well prepared" to tackle challenges posed by the growth of 'big' science as it begins planning its research and operations strategy for the five years starting in 2012, Director General Iain Mattaj said in the institution's annual report for the fiscal year ended March 31.

The report showed a decline in grant funding, especially by the European Community, that pushed EMBL into the red.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.